#6826 on the rich list of 14,644 insiders
Kevin Koch
President and CEO at Edgewise Therapeutics. Based in Boulder, Colorado.
$13.9M
in disclosed stock, −$68K (−0.48%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 6826th of 14,644
- Companies held
- 1
- Largest holding
- EWTX, 100.0% of total
- Latest SEC filing
- Aug 12, 2026
What the $13.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Edgewise Therapeutics EWTX Common Stock | KTK Family Enterprise, LLC | 259,554 | $41.17 | $10.7M | 76.7% | Form 4, Aug 12, 2025 |
| Edgewise Therapeutics EWTX Common Stock | Directly | 52,488 | $41.17 | $2.2M | 15.5% | Form 4, Aug 12, 2026 |
| Edgewise Therapeutics EWTX Common Stock | Adrienne R. Koch Heritage Trust | 26,410 | $41.17 | $1.1M | 7.8% | Form 4, Aug 12, 2025 |
Share counts are the amounts Kevin Koch reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 6823 | Michael K. Kobayashi PRES., CHIEF CAPABILITY OFC'R, Ross Stores. Emeryville, CA | $13.9M |
| 6824 | John P. Albright PRESIDENT & CEO, CTO Realty Growth. Winter Park, FL | $13.9M |
| 6825 | James P. Nygaard Jr. EVP, Chief Financial Officer, Core Scientific. Dover, DE | $13.9M |
| 6826 | Kevin Koch President and CEO, Edgewise Therapeutics. Boulder, CO | $13.9M |
| 6827 | Peter A. Scott President and CEO, Healthcare Realty Trust. Nashville, TN | $13.9M |
| 6828 | Stephen C. Petrovich EVP, GC and Secretary, Ardent Health. Brentwood, TN | $13.9M |
| 6829 | Jerald K. Dittmer Director, Flexsteel Industries. Dubuque, IA | $13.9M |
Other Edgewise Therapeutics insiders
All EWTX insiders- Jonathan D. Root$643KDirector. #7686 overall
Questions
How much stock does Kevin Koch own?
Kevin Koch holds $13,934,069 in listed stock based on SEC filings and current prices, mostly Edgewise Therapeutics (EWTX). That ranks 6826th on the Stock Rich List.
Is this Kevin Koch's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Kevin Koch last buy or sell stock?
The most recent open-market trade on file is a sale of 8,276 EWTX shares on Aug 12, 2026 at $43.66.